ModelEdge

Cidara Therapeutics Inc.
CDTX
Filing Type10-K
Filing Date3/5/2025
Updated3/6/25, 2:25 PM

Filing

10-K
Earnings Release

Exhibits

10-KFY 2024
EX-4.5DESCRIPTION OF THE REGISTRANT'S SECURITIES
EX-10.5NON-EMPLOYEE DIRECTOR COMPENSATION POLICY, AS AMENDED
EX-10.72020 INDUCEMENT INCENTIVE PLAN, AS AMENDED
EX-10.30EXECUTIVE OFFICERS EMPLOYMENT AGREEMENT, AS AMENDED
EX-19.1INSIDER TRADING POLICY
EX-23.1CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
EX-31.1CERTIFICATION OF CEO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934
EX-31.2CERTIFICATION OF CFO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934
EX-32.1CERTIFICATION OF CEO PURSUANT TO SARBANES-OXLEY ACT OF 2002
EX-32.2CERTIFICATION OF CFO PURSUANT TO SARBANES-OXLEY ACT OF 2002
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic